Antibodies, viruses and vaccines

Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein

Ulmer, J. B., Donnelly, J., Parker, S. E., Rhodes, G. H., Felgner, P. L., Dwarki, V., Gromkowski, S. H., Deck, R. R., DeWitt, C. M., Friedman, A., et al. (1993) · Science · doi:10.1126/science.8456302 · Cited by 2,318 · see citing works

Control of Viremia in Simian Immunodeficiency Virus Infection by CD8 + Lymphocytes

Schmitz, J. E., Kuroda, M. J., Santra, S., Sasseville, V. G., Simon, M. A., Lifton, M. A., Rácz, P., Tenner‐Racz, K., Dalesandro, M. R., Scallon, B. J., et al. (1999) · Science · doi:10.1126/science.283.5403.857 · Cited by 2,167 · see citing works

Effector and memory T-cell differentiation: implications for vaccine development

Kaech, S. M., Wherry, E. J., & Ahmed, R. (2002) · Nature Reviews Immunology · doi:10.1038/nri778 · Cited by 1,865 · see citing works

Dramatic Rise in Plasma Viremia after CD8+ T Cell Depletion in Simian Immunodeficiency Virus–infected Macaques

Jin, X., Bauer, D. E., Tuttleton, S., Lewin, S. R., Gettie, A., Blanchard, J., Irwin, C. E., Safrit, J. T., Mittler, J. E., Weinberger, L. S., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.6.991 · Cited by 1,405 · see citing works

Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants.

The IMpact-RSV Study Group (1998) · Pediatrics · doi:10.1542/peds.102.3.531 · Cited by 1,201 · see citing works

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

Shiver, J. W., Fu, T., Chen, L., Casimiro, D. R., Davies, M.-E., Evans, R. K., Zhang, Z., Simon, A. J., Trigona, W. L., Dubey, S. A., et al. (2002) · Nature · doi:10.1038/415331a · Cited by 1,173 · see citing works

Antibody Protects Macaques against Vaginal Challenge with a Pathogenic R5 Simian/Human Immunodeficiency Virus at Serum Levels Giving Complete Neutralization In Vitro

Parren, P. W. H. I., Marx, P. A., Hessell, A. J., Luckay, A., Harouse, J. M., Cheng‐Mayer, C., Moore, J. P., & Burton, D. R. (2001) · Journal of Virology · doi:10.1128/jvi.75.17.8340-8347.2001 · Cited by 663 · see citing works

The Critical Need for CD4 Help in Maintaining Effective Cytotoxic T Lymphocyte Responses

Kalams, S. A., & Walker, B. D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2199 · Cited by 660 · see citing works

Cellular immune responses to HIV

McMichael, A. J., & Rowland‐Jones, S. (2001) · Nature · doi:10.1038/35073658 · Cited by 617 · see citing works

Evidence That Maternal Dengue Antibodies Are Important in the Development of Dengue Hemorrhagic Fever in Infants

Kliks, S. C., Nimmanitya, S., Nisalak, A., & Burke, D. S. (1988) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1988.38.411 · Cited by 577 · see citing works

DISQUISITIONS ON ORIGINAL ANTIGENIC SIN

Groth, S., & Webster, R. G. (1966) · The Journal of Experimental Medicine · doi:10.1084/jem.124.3.331 · Cited by 577 · see citing works

Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.

Alexander‐Miller, M. A., Leggatt, G. R., & Berzofsky, J. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4102 · Cited by 511 · see citing works

Protective Effect of Rotavirus VP6-Specific IgA Monoclonal Antibodies That Lack Neutralizing Activity

Burnsxp, J. W., Siadat‐Pajouh, M., Krishnaney, A. A., & Greenberg, H. B. (1996) · Science · doi:10.1126/science.272.5258.104 · Cited by 494 · see citing works

NEUTRALIZING ANTIVIRAL B CELL RESPONSES

Bachmann, M. F., & Zinkernagel, R. M. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.235 · Cited by 470 · see citing works

Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1

Roben, P., Moore, J. P., Thali, M., et al. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.4821-4828.1994 · Cited by 460 · see citing works

DISTURBANCES IN GAMMA GLOBULIN SYNTHESIS AS "EXPERIMENTS OF NATURE"

Good, R. A., & Zak, S. J. (1956) · PEDIATRICS · doi:10.1542/peds.18.1.109 · Cited by 415 · see citing works

Vaccination Strategies for Mucosal Immune Responses

Ogra, P. L. O., Faden, H. S., & Welliver, C. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.2.430-445.2001 · Cited by 390 · see citing works

Antibody-Mediated Clearance of Alphavirus Infection From Neurons

Levine, B., Hardwick, J. M., Trapp, B. D., Crawford, T. O., Bollinger, R. C., & Griffin, D. E. (1991) · Science · doi:10.1126/science.1658936 · Cited by 361 · see citing works

Functional avidity maturation of CD8+ T cells without selection of higher affinity TCR

Slifka, M. K., & Whitton, J. L. (2001) · Nature Immunology · doi:10.1038/90650 · Cited by 344 · see citing works

Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer.

Sattentau, Q. J., & Moore, J. P. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.1.185 · Cited by 336 · see citing works

Long-lived plasma cells: a mechanism for maintaining persistent antibody production

Slifka, M. K., & Ahmed, R. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80162-3 · Cited by 321 · see citing works

Intracellular Neutralization of HIV Transcytosis across Tight Epithelial Barriers by Anti-HIV Envelope Protein dIgA or IgM

Bomsel, M., Heyman, M., Hocini, H., Lagaye, S., Bélec, L., Dupont, C. M., & Des̀granges, C. (1998) · Immunity · doi:10.1016/s1074-7613(00)80610-x · Cited by 299 · see citing works

Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies

Mazanec, M. B., Coudret, C. L., & Fletcher, D. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.2.1339-1343.1995 · Cited by 296 · see citing works

Maternal Antibodies, Childhood Infections, and Autoimmune Diseases

Zinkernagel, R. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmra012493 · Cited by 296 · see citing works

Effector Function Activities of a Panel of Mutants of a Broadly Neutralizing Antibody against Human Immunodeficiency Virus Type 1

Hezareh, M., Hessell, A. J., Jensen, R. C., van de Winkel, J. G. J., & Parren, P. W. H. I. (2001) · Journal of Virology · doi:10.1128/jvi.75.24.12161-12168.2001 · Cited by 294 · see citing works

Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates

Sullivan, N. R., Sun, Y., Li, J., et al. (1995) · Journal of Virology · doi:10.1128/jvi.69.7.4413-4422.1995 · Cited by 292 · see citing works

The antiviral activity of antibodies in vitro and in vivo

Parren, P., & Burton, D. (2004) · Advances in Immunology · doi:10.1016/s0065-2776(01)77018-6 · Cited by 281 · see citing works

Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats

Prince, G. A., Horswood, R. L., & Chanock, R. M. (1985) · Journal of Virology · doi:10.1128/jvi.55.3.517-520.1985 · Cited by 245 · see citing works

Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs

Ochsenbein, A. F., Pinschewer, D. D., Sierro, S. R., Horváth, E. J., Hengartner, H., & Zinkernagel, R. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.230417497 · Cited by 224 · see citing works

The Role of the Antibody Response in Influenza Virus Infection

Gerhard, W. (2001) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-05783-4_9 · Cited by 211 · see citing works

Immune Enhancement of Viral Infection

Halstead, S. B. (2015) · Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy · doi:10.1159/000406537 · Cited by 210 · see citing works

The influence of virus structure on antibody responses and virus serotype formation

Bachmann, M. F., & Zinkernagel, R. M. (1996) · Immunology Today · doi:10.1016/s0167-5699(96)10066-9 · Cited by 205 · see citing works

Synergistic Interactions of Anti-NS1 Monoclonal Antibodies Protect Passively Immunized Mice from Lethal Challenge with Dengue 2 Virus

Henchal, E. A., Henchal, L. S., & Schlesinger, J. J. (1988) · Journal of General Virology · doi:10.1099/0022-1317-69-8-2101 · Cited by 204 · see citing works

Pre- and Postexposure Prophylaxis of Ebola Virus Infection in an Animal Model by Passive Transfer of a Neutralizing Human Antibody

Parren, P. W. H. I., Geisbert, T. W., Maruyama, T., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.12.6408-6412.2002 · Cited by 204 · see citing works

INFLUENZA: THE NEWE ACQUAYANTANCE

FRANCIS, T. (1953) · Annals of Internal Medicine · doi:10.7326/0003-4819-39-2-203 · Cited by 182 · see citing works

Prospects for Vaccine Protection Against HIV-1 Infection and AIDS

Letvin, N. L., Barouch, D. H., & Montefiori, D. C. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.081501.094854 · Cited by 179 · see citing works

Viruses, Plagues, and History

Oldstone, M. B. A. (2020) · doi:10.1093/oso/9780190056780.001.0001 · Cited by 172 · see citing works

HIV-1 neutralization: the consequences of viral adaptation to growth on transformed T cells.

Jp, M., & Ho, D. D. (1995) · PubMed · Cited by 171 · see citing works

Determination of a Statistically Valid Neutralization Titer in Plasma That Confers Protection against Simian-Human Immunodeficiency Virus Challenge following Passive Transfer of High-Titered Neutralizing Antibodies

Nishimura, Y., Igarashi, T., Haigwood, N. L., Sadjadpour, R., Plishka, R. J., Buckler-White, A. J., Shibata, R., & Martin, M. A. (2002) · Journal of Virology · doi:10.1128/jvi.76.5.2123-2130.2002 · Cited by 161 · see citing works

Viruses, Plagues, and History

Smith, G. L. (1998) · Nature Medicine · doi:10.1038/3325 · Cited by 153 · see citing works

New hope for an aids vaccine

Robinson, H. L. (2002) · Nature reviews. Immunology · doi:10.1038/nri776 · Cited by 153 · see citing works

HIV-1 antibody — debris or virion?

Parren, P. W. H. I., Burton, D. R., & Sattentau, Q. J. (1997) · Nature Medicine · doi:10.1038/nm0497-366d · Cited by 151 · see citing works

Antiviral antibody reacting on the plasma membrane alters measles virus expression inside the cell

Fujinami, R. S., & Oldstone, M. B. A. (1979) · Nature · doi:10.1038/279529a0 · Cited by 142 · see citing works

Immunity to retroviral infection: The Friend virus model

Hasenkrug, K. J., & Chesebro, B. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.7811 · Cited by 128 · see citing works

The quest for an AIDS vaccine: is the CD8+ T-cell approach feasible?

McMichael, A. J., & Hanke, T. (2002) · Nature reviews. Immunology · doi:10.1038/nri779 · Cited by 127 · see citing works

Tat-Vaccinated Macaques Do Not Control Simian Immunodeficiency Virus SIVmac239 Replication

Allen, T. M., Mortara, L., Mothé, B. R., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.8.4108-4112.2002 · Cited by 110 · see citing works

Long-term humoral immunity against viruses: revisiting the issue of plasma cell longevity

Slifka, M. K., & Ahmed, R. (1996) · Trends in Microbiology · doi:10.1016/0966-842x(96)10059-7 · Cited by 109 · see citing works

Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus

Kulkarni, A. B., Collins, P. L., Bacik, I., et al. (1995) · Journal of Virology · doi:10.1128/jvi.69.2.1261-1264.1995 · Cited by 102 · see citing works

Recombinant human Fab to glycoprotein D neutralizes infectivity and prevents cell-to-cell transmission of herpes simplex viruses 1 and 2 in vitro.

Burioni, R., Williamson, R. A., Sanna, P. P., et al. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.355 · Cited by 101 · see citing works

Requirement for multiple lymphocyte subsets in protection by a live attenuated vaccine against retroviral infection

Dittmer, U., Brooks, D. M., & Hasenkrug, K. J. (1999) · Nature Medicine · doi:10.1038/5550 · Cited by 100 · see citing works

The enhancement of virus infectivity by antibody

Hawkes, R. A., & Lafferty, K. J. (1967) · Virology · doi:10.1016/0042-6822(67)90144-4 · Cited by 99 · see citing works

Opsonization-enhanced phagocytosis of foot-and-mouth disease virus.

McCullough, K. C., Parkinson, D., & Crowther, J. R. (1988) · PubMed · Cited by 91 · see citing works

PREDETERMINATION BY INFECTION AND BY VACCINATION OF ANTIBODY RESPONSE TO INFLUENZA VIRUS VACCINES

Davenport, F. M., Hennessy, A. V., & Fabisch, W. T. T. A. O. P. H. (1957) · The Journal of Experimental Medicine · doi:10.1084/jem.106.6.835 · Cited by 88 · see citing works

Neutralizing antiviral antibody responses

Zinkernagel, R. M., Lamarre, A., Ciurea, A., Hunziker, L., Ochsenbein, A. F., McCoy, K. D., Fehr, T. H., Bachmann, M. F., Kalinke, U., & Hengartner, H. (2001) · Advances in immunology · doi:10.1016/s0065-2776(01)79001-3 · Cited by 85 · see citing works

Antibody-Mediated Enhancement of Viral Disease

Sullivan, N. J. (2001) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-05783-4_8 · Cited by 79 · see citing works

Immunocytochemical Colocalization of Specific Immunoglobulin A with Sendai Virus Protein in Infected Polarized Epithelium

Fujioka, H., Emancipator, S. N., Aikawa, M., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.7.1223 · Cited by 79 · see citing works

Vaccines 93: Modern approaches to new vaccines including prevention of AIDS

Spier, R. E. (1994) · Vaccine · doi:10.1016/0264-410x(94)90132-5 · Cited by 77 · see citing works

Neutralizing Antibodies Protect against Lethal Flavivirus Challenge but Allow for the Development of Active Humoral Immunity to a Nonstructural Virus Protein

Kreil, T. R., Maier, E., Fraiss, S., & Eibl, M. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.3076-3081.1998 · Cited by 76 · see citing works

Immunological Reactions of the Filterable Viruses

(1938) · Nature · doi:10.1038/141983b0 · Cited by 72 · see citing works

Comparison of IgA versus IgG monoclonal antibodies for passive immunization of the murine respiratory tract

Mazanec, M. B., Lamm, M. E., Lyn, D., Portner, A., & Nedrud, J. G. (1992) · Virus Research · doi:10.1016/0168-1702(92)90063-f · Cited by 69 · see citing works

Use of Concentrated Human Serum gamma-Globulin in the Prevention and Attenuation of Measles.

(1945) · PubMed Central · Cited by 67 · see citing works

Neutralizing F(ab')2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope protein fail to protect mice against lethal YF encephalitis

Schlesinger, J. J., & Chapman, S. (1995) · Journal of General Virology · doi:10.1099/0022-1317-76-1-217 · Cited by 65 · see citing works

Profiles of antibody-dependent enhancement of dengue virus type 2 infection

Morens, D. M., Halstead, S. B., & Marchette, N. J. (1987) · Microbial Pathogenesis · doi:10.1016/0882-4010(87)90056-8 · Cited by 64 · see citing works

The Clinical Use of Gamma Globulin

Krugman, S. (1963) · New England Journal of Medicine · doi:10.1056/nejm196307252690406 · Cited by 63 · see citing works

Vaccines and the induction of functional antibodies: Time to look beyond the molecules of natural infection?

Burton, D. R., & Parren, P. W. H. I. (2000) · Nature Medicine · doi:10.1038/72200 · Cited by 58 · see citing works

Antiviral antibodies attenuate T-cell-mediated immunopathology following acute lymphocytic choriomeningitis virus infection

Wright, K. E., & Buchmeier, M. J. (1991) · Journal of Virology · doi:10.1128/jvi.65.6.3001-3006.1991 · Cited by 57 · see citing works

Update on the neutralisation of animal viruses

Dimmock, N. (1995) · Reviews in Medical Virology · doi:10.1002/rmv.1980050306 · Cited by 56 · see citing works

Human Antibody Responses to Mature and Immature Forms of Viral Envelope in Respiratory Syncytial Virus Infection: Significance for Subunit Vaccines

Sakurai, H., Williamson, R. A., Crowe, J. E., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.2956-2962.1999 · Cited by 56 · see citing works

CD8+ cytotoxic T lymphocyte responses to lentiviruses and herpesviruses

Barouch, D. H., & Letvin, N. L. (2001) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00244-2 · Cited by 52 · see citing works

Vaccine-induced cytotoxic T lymphocytes protect against retroviral challenge

Hislop, A. D., Good, M. F., Mateo, L., et al. (1998) · Nature Medicine · doi:10.1038/2690 · Cited by 51 · see citing works

Role of Antibodies in Controlling Viral Disease: Lessons from Experiments of Nature and Gene Knockouts

Sanna, P. P., & Burton, D. R. (2000) · Journal of Virology · doi:10.1128/jvi.74.21.9813-9817.2000 · Cited by 47 · see citing works

Prevention or Modification of Varicella Using Zoster Immune Plasma

Balfour, H. H. (1977) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1977.02120190087020 · Cited by 43 · see citing works

Viral spread in the presence of neutralizing antibody: mechanisms of persistence in foamy virus infection

Hooks, J. J., Burns, W. H., Hayashi, K., et al. (1976) · Infection and Immunity · doi:10.1128/iai.14.5.1172-1178.1976 · Cited by 41 · see citing works

The CD4+ T cell response to HIV-1

Picker, L. J., & Maino, V. C. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00104-7 · Cited by 40 · see citing works

Human monoclonal antibody Fab fragments cloned from combinatorial libraries: potential usefulness in prevention and/or treatment of major human viral diseases.

Rm, C., Crowe, J. E., Br, M., et al. (1993) · PubMed · Cited by 36 · see citing works

Effect of anti‐V3 antibodies on cell‐free and cell‐to‐cell human immunodeficiency virus transmission

Pantaleo, G., Demarest, J. F., Vaccarezza, M., et al. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250137 · Cited by 30 · see citing works

Human trials of AIDS vaccines

Koff, W. C., & Fauci, A. S. (1989) · AIDS · doi:10.1097/00002030-198901001-00018 · Cited by 25 · see citing works

The Role of the Complement System in Virus Infections

Spear, G. T., Hart, M. L., Olinger, G. G., Hashemi, F. B., & Saifuddin, M. (2001) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-05783-4_12 · Cited by 25 · see citing works

Merck Reemerges With a Bold AIDS Vaccine Effort

Cohen, J. D. (2001) · Science · doi:10.1126/science.292.5514.24 · Cited by 23 · see citing works

Role of Mucosal Antibodies in Viral Infections

Kato, H., Kato, R., Fujihashi, K., & McGhee, J. R. (2001) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-05783-4_11 · Cited by 23 · see citing works

Different Immunological Requirements for Protection Against Acute versus Persistent Friend Retrovirus Infections

Dittmer, U., & Hasenkrug, K. J. (2000) · Virology · doi:10.1006/viro.2000.0356 · Cited by 20 · see citing works

Original Antigenic Sin: Experiments with a defined antigen

East, I. J., Todd, P. E. E., & Leach, S. J. (1980) · Molecular Immunology · doi:10.1016/0161-5890(80)90179-0 · Cited by 20 · see citing works

Delayed Emergence of Bovine Leukemia Virus after Vaccination with a Protective Cytotoxic T Cell-Based Vaccine

Mateo, L., Gardner, J., & Suhrbier, A. (2001) · AIDS Research and Human Retroviruses · doi:10.1089/088922201753197114 · Cited by 16 · see citing works

Data on the efficiency of specific antimumps immunoglobulins in the prevention of mumps and of its complications.

Copelovici, Y., Strulovici, D., Al, C., et al. (1980) · PubMed · Cited by 16 · see citing works

Protection of Nonimmune Volunteers against Rubella by Intravenous Administration of Normal Human Gamma Globulin

Pan, R. M. D., Koechli, B., & Donath, A. (1972) · The Journal of Infectious Diseases · doi:10.1093/infdis/126.3.341 · Cited by 14 · see citing works

Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

McLellan, J. S., Chen, M., Joyce, M. G., Sastry, M., Stewart-Jones, G. B. E., Yang, Y., Zhang, B., Chen, L., Srivatsan, S., Zheng, A., et al. (2013) · Science · doi:10.1126/science.1243283 · Cited by 1,126 · see citing works

Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors

Jardine, J., Julien, J.-P., Menis, S., Ota, T., Kalyuzhniy, O., McGuire, A., Sok, D., Huang, P.-S., MacPherson, S., Jones, M., et al. (2013) · Science · doi:10.1126/science.1234150 · Cited by 770 · see citing works

Structural definition of a conserved neutralization epitope on HIV-1 gp120

Zhou, T., Xu, L., Dey, B., Hessell, A. J., Van Ryk, D., Xiang, S.-H., Yang, X., Zhang, M.-Y., Zwick, M. B., Arthos, J., et al. (2007) · Nature · doi:10.1038/nature05580 · Cited by 770 · see citing works

Virus entry: molecular mechanisms and biomedical applications

Dimitrov, D. S. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro817 · Cited by 701 · see citing works

Adenoviruses as vaccine vectors

Tatsis, N., & Ertl, H. C. J. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.07.013 · Cited by 669 · see citing works

Proof of principle for epitope-focused vaccine design

Correia, B. E., Bates, J. T., Loomis, R. J., Baneyx, G., Carrico, C., Jardine, J. G., Rupert, P., Correnti, C., Kalyuzhniy, O., Vittal, V., et al. (2014) · Nature · doi:10.1038/nature12966 · Cited by 555 · see citing works

Lack of Peripheral Memory B Cell Responses in Recovered Patients with Severe Acute Respiratory Syndrome: A Six-Year Follow-Up Study

Tang, F., Quan, Y., Xin, Z.-T., Wrammert, J., Ma, M.-J., Lv, H., Wang, T.-B., Yang, H., Richardus, J. H., Liu, W., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.0903490 · Cited by 496 · see citing works

HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits

Xu, W., Santini, P. A., Sullivan, J. S., He, B., Shan, M., Ball, S. C., Dyer, W. B., Ketas, T. J., Chadburn, A., Cohen-Gould, L., et al. (2009) · Nature Immunology · doi:10.1038/ni.1753 · Cited by 302 · see citing works

Accelerating Next-Generation Vaccine Development for Global Disease Prevention

Koff, W. C., Burton, D. R., Johnson, P. R., Walker, B. D., King, C. R., Nabel, G. J., Ahmed, R., Bhan, M. K., & Plotkin, S. A. (2013) · Science · doi:10.1126/science.1232910 · Cited by 282 · see citing works

Contributions of humoral and cellular immunity to vaccine-induced protection in humans

Amanna, I. J., & Slifka, M. K. (2011) · Virology · doi:10.1016/j.virol.2010.12.016 · Cited by 263 · see citing works

Structure-Based Vaccine Antigen Design

Graham, B. S., Gilman, M. S. A., & McLellan, J. S. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-121217-094234 · Cited by 234 · see citing works

Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype

Dowd, K. A., DeMaso, C. R., Pelc, R. S., Speer, S. D., Smith, A. R. Y., Goo, L., Platt, D. J., Mascola, J. R., Graham, B. S., Mulligan, M. J., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.049 · Cited by 206 · see citing works

Mimicking live flavivirus immunization with a noninfectious RNA vaccine

Kofler, R. M., Aberle, J. H., Aberle, S. W., Allison, S. L., Heinz, F. X., & Mandl, C. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307145101 · Cited by 116 · see citing works

New Vaccine Design and Delivery Technologies

Kanekiyo, M., Ellis, D., & King, N. P. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy745 · Cited by 69 · see citing works

Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B

Liu, J., Budylowski, P., Samson, R., Griffin, B. D., Babuadze, G., Rathod, B., Colwill, K., Abioye, J. A., Schwartz, J. A., Law, R., et al. (2022) · Science Advances · doi:10.1126/sciadv.abj9815 · Cited by 56 · see citing works

Passive immunization for the public health control of communicable diseases: Current status in four high-income countries and where to next

Young, M. K., & Cripps, A. W. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.25311 · Cited by 16 · see citing works

Neutralizing antibody response in non-hospitalized SARS-CoV-2 patientsPreprint

Ruétalo, N., Businger, R., Althaus, K., et al. (2020) · medRxiv · doi:10.1101/2020.08.07.20169961 · Cited by 9 · see citing works

Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma

Maeda, K., Higashi‐Kuwata, N., Kinoshita, N., Kutsuna, S., Tsuchiya, K., Hattori, S.-I., Matsuda, K., Takamatsu, Y., Gatanaga, H., Oka, S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-84733-5 · Cited by 46 · see citing works

Heterogeneity in the Properties of 7 S and 19 S Rabbit-Neutralizing Antibodies to Herpes Simplex Virus

Hampar, B., Notkins, A. L., Mage, M. G., et al. (1968) · The Journal of Immunology · doi:10.4049/jimmunol.100.3.586 · Cited by 100 · see citing works

Modeling the kinetics of the neutralizing antibody response against SARS-CoV-2 variants after several administrations of Bnt162b2

Clairon, Q., Prague, M., Planas, D., Bruel, T., Hocqueloux, L., Prazuck, T., Schwartz, O., Thiébaut, R., & Guedj, J. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011282 · Cited by 22 · see citing works

Comparison of potency assays to assess SARS-CoV-2 neutralizing antibody capacity in COVID-19 convalescent plasma

von Rhein, C., Scholz, T., Henß, L., Kronstein‐Wiedemann, R., Schwarz, T., Rodionov, R. N., Corman, V. M., Tonn, T., & Schnierle, B. S. (2020) · Journal of Virological Methods · doi:10.1016/j.jviromet.2020.114031 · Cited by 81 · see citing works